2016-2020 U.S. Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

March 2016 | 436 pages | ID: 2B9757672AAEN
Venture Planning Group

Abstracts

Complete report $9,850. DataPack (test volumes, sales forecasts, supplier shares) $6,400.

VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the U. S. automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding U. K. microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis

Sales and market shares for major suppliers by individual test.

Volume and sales forecasts for over 100 infectious disease assays by individual test:

• Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).
• Review of the market dynamics, trends, structure, size, growth and major suppliers.

Specimen Types

• Urine
• Sterile Fluids: Blood, Serum, CSF
• Throat Swabs, Respiratory Secretions
• Genital Secretions
• Stool
• Abscess/Wound
• Sputum
• Saliva

Applications

• Microbial Identification
• Antibiotic Susceptibility
• Urine Screening
• Blood Cultures

Review of Major Automated Systems

• Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.
• The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus, Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Technology Review

• Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.
• Global listings of companies developing or marketing microbiology products by individual test.

Competitive Assessments

• Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.

The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Biotest, CellMark Forensics/LabCorp, Cepheid, Decode Genetics, Diadexus, Diamedix/Erba, DiaSorin, Eiken Chemical, Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, ID Biomedical/GSK, Illumina, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Shimadzu, Siemens, Sierra Molecular, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.

Opportunities and Strategic Recommendations

• Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.
• Design criteria for decentralized testing products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 436 pages and 94 tables

Contents

1. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. INTRODUCTION

  1. MAJOR FACTORS AFFECTING MARKET PENETRATION OF MICROBIOLOGY INSTRUMENTATION
  2. TRADITIONAL PRACTICES
  3. TECHNOLOGICAL CHALLENGES
  4. AUTOMATION: IMPACT ON THE MICROBIOLOGY LABORATORY AND THE PATIENT
B. Major Specimen Types
  1. URINE
  2. STERILE FLUIDS: BLOOD, SERUM, AND CSF
  3. THROAT SWABS AND RESPIRATORY SECRETIONS
  4. GENITAL SECRETIONS
  5. STOOL
  6. ABSCESS/WOUND
  7. SPUTUM
  8. SALIVA
C. Test Applications
  1. MICROBIAL IDENTIFICATION
  2. ANTIBIOTIC SUSCEPTIBILITY
  3. URINE SCREENING
    a. Photometry
    b. Bioluminescence
    c. Colorimetric Filtration
    d. Enzymatic Detection
    e. Optical Detection
  4. BLOOD CULTURES
D. Major Microbiology Automated and Semiautomated Systems
  1. MULTIPLE PURPOSE MICROBIOLOGY SYSTEMS
  2. SPECIALIZED MICROBIOLOGY SYSTEMS
  3. MOLECULAR DIAGNOSTIC SYSTEMS
  4. IMMUNODIAGNOSTIC SYSTEMS
E. Emerging Diagnostic Technologies
  1. MOLECULAR DIAGNOSTICS
    a. DNA Sequencing
      INTRODUCTION
      Sequencing Methods
      Autoradiography
      The Human Genome Project
      Sequencing Automation
      Image Scanners
      Fluorescent Detection
      Gene Profiling
      Gene Expression
      Polymorphism Screening
      Protein Interaction Networks
    b. DNA And RNA Probe Technology
      Basic Principles
      Probe Preparation
      The DNA Probe Test
      Sample Preparation
      Hybridization
      Separation
      Detection/Measurement
      Test Formats
      Filter Hybridization
      Southern Blot
      Northern Blot
      In Situ Hybridization
      Others
      Labeling Techniques
      Amplification Methods
      Polymerase Chain Reaction
      Temperature Cyclers
      PCR Variations
      ImmunoPCR
    QCPCR
    DAPPCR
    Strand Displacement Activation
    TMA
    Ligase Chain Reaction
    Branched DNA
      Hybridization Protection Assay
    NucleicAcid SequenceBased Amplification
    SelfSustained Sequence Replicase
    Others
      Ampliprobe
      CAR
      CAS
      CPT
      Dendritic Polymer Technology
      ISOCR
      LAT
      Probe
      RAMP
      Repair Chain Reaction
      Rolling Circles
      Sequence Independent Gene Amplification
      Sequence Initiation Reaction
      SISPA
      Solid Phase Amplification
    c. Detection Technologies
      Radioactive Methods
      Overview
      Major Isotopes
        P
        S
        H
        I
      NonIsotopic Methods
      Enzymatic Labels
      Chemical Labeling
    Indirect Chemical Labeling
    Direct Chemical Labeling
      Fluorescence
      Chemiluminescence
      Electrical Conductivity
    d. Biochips: Genosensors, Microarrays, and LabsontheChip
      Liquid Transportation and Mixing
      Separation
      Reaction
      Detection
  2. MONOCLONAL ANTIBODIES
  3. IMMUNOASSAYS
  4. DIFFERENTIAL LIGHT SCATTERING
  5. INFORMATION TECHNOLOGY
  6. ARTIFICIAL INTELLIGENCE
  7. LIPOSOMES
  8. FLOW CYTOMETRY
  9. CHROMATOGRAPHY
  10. DIAGNOSTIC IMAGING
  11. GEL MICRODROPLETS
  12. OTHER

2. UK

A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares

3. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKETING APPROACHES
  2. PRODUCT COMPLEXITY
  3. CUSTOMER PREFERENCE
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION

7. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

8. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
BioRad
Biotest
Cepheid
CellMark Forensics/Lab Corp
Decode Genetics
Diadexus
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/GenProbe
Illumina
ID Biomedical/GSK
Kreatech/Leica
LiCor Biosciences
Lonza
Monogram Biosciences
Myriad Genetics
OrthoClinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Sierra Molecular
Shimadzu
Takara Bio
Tecan
Thermo Fisher
Wallac/PE
Wako

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.K. Laboratories Performing Microbiology Tests by Market Segment
U.K. Hospital Laboratories Performing Microbiology Tests by Bed Size
U.K. Commercial/Private Laboratories Performing Microbiology Tests by Annual Test Volume
U.K. All Market Segments Microbiology Specimen Volume
U.K. Hospital Laboratories Microbiology Specimen Volume
U.K. Public Health Laboratories Microbiology Specimen Volume
U.K. Commercial/Private Laboratories Microbiology Specimen Volume
U.K. Microbiology Test Volume by Market Segment
U.K. Microbiology Test Volume by Application
U.K. Microbial Identification Test Volume by Market Segment
U.K. Urine Screening Test Volume by Market Segment
U.K. Antibiotic Susceptibility Test Volume by Market Segment
U.K. Blood Culture Test Volume by Market Segment
U.K. Microbiology Consumables Market by Application
U.K. Microbiology Consumables Market by Market Segment
U.K. Microbial Identification Consumables Sales by Market Segment
U.K. Antibiotic Susceptibility Consumables Sales by Market Segment
U.K. Blood Culture Consumables Sales by Market Segment
U.K. Urine Screening Consumables Sales by Market Segment
U.K. All Market Segments Infectious Disease Test Volume Forecast by Assay
U.K. All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.K. Infectious Disease Blood Screening NAT Volume Forecast by Assay
U.K. Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.K. HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales by Major Supplier
U.K. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.K. Candida Testing Market Diagnostics Sales by Major Supplier
U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.K. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.K. Influenza Testing Market Diagnostics Sales by Major Supplier
U.K. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.K. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.K. RSV Testing Market Diagnostics Sales by Major Supplier
U.K. Rubella Testing Market Diagnostics Sales by Major Supplier
U.K. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.K. Shigella Testing Market Diagnostics Sales by Major Supplier
U.K. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.K. Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.K. Molecular Diagnostics Market Sales and Shares of Major Suppliers